Global Blood and Plasma Collections and Use 2023–2024: Trends, Regulations, and Market Insights
Dana Miloslavich, Director Of Research at The Marketing Research Bureau Inc, shared on LinkedIn:
“The Marketing Research Bureau is pleased to announce the completion of the following report:
GLOBAL BLOOD AND PLASMA COLLECTIONS AND USE – 2023/2024
This new MRB report presents a global overview of blood collections and an analysis of all the sources of plasma used for fractionation from over 85 countries.
Plasma collection regulations and the historical context for those regulations are detailed in many countries, including plasma recovered from whole blood donations, as well as source plasma collected by public/non-profit entities and private companies.
Today, most of the plasma for fractionation is collected in the United States, but high collection costs constitute a cause of concern for those markets that largely depend on U.S. plasma.
Therefore, a good understanding of the potential for sourcing plasma from outside the U.S. is essential for planning and forecasting. In addition, awareness of plasma volumes collected in each individual country helps to inform both its current self-sufficiency level and quantities of imported plasma proteins needed to address its domestic market needs.
In addition to data on plasma for fractionation and whole blood collections, quantitative information on other blood components is included for those countries where such figures could be accessed.
Presented data are based on an extensive survey conducted by MRB in over 85 countries in 2023 and 2024. In addition to 2024 full-year figures for plasma fractionation, the report provides historical data going back 10 or more years as available”
Read more here.
More insights on Hemostasis Today.
-
Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
-
Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
-
Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
-
Oct 30, 2025, 07:42Carmelo Gurnari Leads Leukemia Research at Cleveland Clinic and Champions Care Grounded in Partnership
-
Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
-
Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
-
Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
-
Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
-
Oct 30, 2025, 07:40Dr Gee Teak Sheng: Visibility is Safety — and in UBE Spine Surgery, That Clarity Begins with Hemostasis
-
Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
-
Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
-
Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague